Introduction
Chondrosarcoma are a heterogenous group of primary malignant bone tumours, and are the third most common primary malignant bone tumour (Dorfman and Czerniak, 1995) . Intracranial chondrosarcomas however are a rare entity, and account for only 0.15% of all intracranial tumours (Bloch et al., 2009 , Bloch and Parsa, 2013 , Bloch et al., 2010 .
The median survival time for patients with intracranial chondrosarcoma has been reported to be approximately 24 months with 11.5% 5-year mortality (Bloch et al., 2009) . Whilst this is consistent with previous studies (Oghalai et al., 2005 , Colli and Al-Mefty, 2001), the largest study of intracranial chondrosarcoma, by Rosenberg et al., 1999, demonstrates a 5-year survival of 99% when surgery is combined with adjuvant radiotherapy (Rosenberg et al., 1999) . Intracranial Chondrosarcomas arise predominantly at the base of the skull with the most common location being the clivus (32%) followed by the temporo-occipital junction (Bloch et al., 2009 , Khan et al., 2013 . The predilection for the skull base is thought to be related to the difference in bone development as endochondral ossification predominates in the basilar structures of the skull compared to intramembranous ossification in other areas (Bloch and Parsa, 2013) . Chondrosarcomas arise from resting chondrocytes found in areas of mature endochondral ossification. However competing theories of their origin suggest that they may originate from remnants of functional mesenchymal cells involved in the embryogenesis of the skull base, or even the metastasis of mature fibroblasts (Bloch et al., 2009) .
Given the rarity of these tumours, there is significant variability in the therapeutic approach, without conclusive evidence elucidating an evidence-based approach (Bloch and Parsa, 2013) . This case report describes a unique clinical experience of this rare entity, the use of an extended endoscopic endonasal approach (EEA) to the surgical management of a clival tumour and finally the use of a naso-septal flap as a reconstructive method. Overall this report adds support to the use of a minimally invasive approach for the resection of posterior clival lesions with minimal morbidity, fast recovery and reduced hospital stay.
Case Report
A 27 year old female presented with a progressive clival mass. She initially presented in 2010 with headache and diplopia, and was subsequently found to have a petroclival mass ( Figure 1) . A surgical resection was undertaken at the time via a frontotemporal craniotomy. No adjuvant radiotherapy was offered due to patient's concern. Despite a detected recurrence in 2011, conservative management was chosen by the patient due to her asymptomatic status.
In 2013 her tumour had doubled in size, with increasing headache and diplopia. An MRI revealed a cystic mass measuring 21mm x 9mm in the mid-clival region (Figure 2 ). The tumour was right paramidline, but displaced the basilar artery to the left, with mild-distortion of the pons.
Operation
The patient underwent a combined endoscopic endonasal resection of the clival mass. Stereotactic registration was performed utilising fused CT and MRI skull base sequences.
A standard binasal approach was utilised with elevation of a vascularised nasoseptal flap. The posterior half of the nasal septum was removed to widely expose the sphenoid rostrum down to the inferior clivus before proceeding to wide sphenoidectomies and partial posterior ethmoidectomies.
The sella floor and clival recess were identified and the clivus drilled out to the inferior extent of the tumour location. The vidian nerve and artery were identified enabling horizontal and vertical carotid localisation. The clival tumour was exposed and radically debulked, with exposure laterally to Dorello's canal. The dural leaves were separated and resected with tumour enabling clear margins on histopathological frozen section. The basilar artery and perforators were identified and seen displaced to the left. Having resected the tumour to clear margins, a multilayered reconstruction technique was utilised with use of the previously raised naso-septal flap to reconstruct the defect. Duragen (Integra Life Sciences, Plainsboro, NJ) was used as an inlay repair, the flap as an overlay and secured with Tisseel (Baxter Healthcare Corp., Deerfield, IL). Gelfoam was packed against the reconstruction to ensure no dead space and a Foley's balloon catheter was then inserted and inflated to maintain the gelfoam. 
Post-operative Course
Postoperatively the patient had an uncomplicated recovery, with resolution of pre-operative diplopia and headaches. No CSF leak occurred. The foley catheter was removed after 48 hrs and the patient discharged five days post operatively. Histopathological analysis confirmed a low grade chondrosarcoma ( Figure  3 ). The patient underwent focal stereotactic radiotherapy delivered via VolumetricModulated Arc Therapy (VMAT), starting 6 weeks post-operatively. Thirty-four fractions of radiotherapy, with a total dose of 61.20Gray, were delivered over a 7 week period.
At 3 months post-operatively, and 3-weeks post-completion of her radiotherapy treatment the patient had nil neurological deficits or ongoing side effects. Her original symptoms had completely resolved. She was planned for 6-monthly progress MRI.
Discussion

Chondrosarcomas
Chondrosarcomas typically grow as infiltrative, mineralised masses that extend into and destroy surrounding soft tissue and bone (Bloch et al., 2009) . Histologically, chondrosarcomas are divided mainly into conventional and mesenchymal subtypes, with the conventional type being the most common, and mesenchymal accounting for less than 10% of lesions. The mesenchymal type however portends a significantly worse prognosis, with Bloch et al. or venous. Haemostasis has been considered challenging, but of warm irrigation, thrombotic agents and specific endonasal instruments has significantly improved the methods of . 
Adjuvant Radiotherapy
The use of adjuvant radiation therapy combination with surgery is increasingly utilised, reportedly employed in sinonasal chrondrosarcomas diagnosed after 1990 (Khan et al., 2013) . there is a lack of conclusive statistical evidence given the rarity of these tumours, There are various radiotherapy modalities available including fractionated photon radiotherapy, proton therapy, particle therapy with ions and stereotactic radiosurgery.
Conventional External Beam Radiation
Therapy is the traditional option, delivered via highly conformal techniques such as intensity-modulated radiation therapy. Most analyses show a 5-year progression free survival of around 80% with the use of photon radiotherapy (Bloch and Parsa, 2013) . However chondrosarcomas are radio-resistant tumours and doses in excess of 60Gy are required for effective control which can result in radio-toxicity to surrounding structures (Bloch and Other modalities of particle therapy such as carbon ions, and stereotactic radiosurgery are also attractive options that are yet to be conclusively explored (Amichetti et al., 2010) .
Given the array of options for adjuvant radiation therapy, the combination with endoscopic approaches is a promising combination. The quicker recovery associated with the EEA is likely to allow an opportunity to move onto early radiotherapy.
Conclusion
The literature regarding surgical management of chondrosarcomas is limited to small case series with a systematic review bringing together only 161 cases (Khan et al., 2013) . There is a paucity of consensus regarding the most efficacious surgical approaches to chondrosarcomas located in the clival region. A case of an endoscopic endonasal approach taken to resect a recurrent clival chondrosarcoma with post-operative imaging showing complete resection highlights the success of recent advances in skull base surgery. The adjunct of a nasoseptal flap appears to be a successful method of skull base reconstruction. In conclusion, this case endorses a minimally invasive approach to lesions within the posterior clival region as a viable and low morbidity alternative. 
